Antares Pharma, Inc. (ATRS)

[ou71764]

Excellent presentation by Apple - and it's reflected in the price move. I don't know what analyst(s) asked the questions, but they got to the core of some of the things that might have been holding the stock back yesterday.

He effectively addressed the labeling, pricing, and their competency in rolling out Xyosted. He emphasized its superiority to competitors and said that with only 10% market share, that it would be significant to the company. IMO they'll get far more than 10%. I believe ATRS will be a big winner for investors.